Sinopharm Group Co Ltd 1099 Financial and Strategic SWOT Analysis Review [Report Updated: 23052018] Prices from USD $125

06:03 EDT 7 Aug 2018 | BioPortfolio Reports

Sinopharm Group Co Ltd 1099 Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Sinopharm Group Co Ltd Sinopharm, a subsidiary of China National Pharmaceutical Group Corp is a distributor of pharmaceutical and healthcare products. The group provides distribution, logistics and other valueadded services to foreign and domestic manufacturers and suppliers of pharmaceuticals, medical products and supplies and other healthcare products. It also serves hospitals, retail drug stores and primary health services institutions. Sinopharm also manufactures and sells pharmaceuticals, chemical reagents and laboratory supplies, and engages in the innovation of pharmaceutical, medical services and other healthrelated industries. Besides, the group manages a chain of medicine stores across China through direct operations and franchises to market pharmaceutical and healthcare products. Sinopharm is headquartered in Shanghai, China.

Sinopharm Group Co Ltd Key Recent Developments

Jul 31,2017: Sinopharm Group: Proposed Re Election And Appointment Of Directors And Supervisors

May 31,2017: Sinopharm Launches New Logo

May 17,2017: Sinopharm International Wins Medical Equipment Contract from Serbia Ministry of Health

Mar 24,2017: Sinopharm Group: Annual results announcement for the year ended 31 December 2016

Mar 24,2017: Sinopharm Group: Change in chairman of the board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Sinopharm Group Co Ltd 1099 Financial and Strategic SWOT Analysis Review [Report Updated: 23052018] Prices from USD $125


More From BioPortfolio on "Sinopharm Group Co Ltd 1099 Financial and Strategic SWOT Analysis Review [Report Updated: 23052018] Prices from USD $125"

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...